Cubist in the News

Showing Media Items: 78 of 8

27 Feb 2013

Cave Explorer Hunts Antibiotics 1,600 Feet Down: Health

Bloomberg - 2/27/13

By teaming with Barton, Cubist is betting that drug discovery in nature, long abandoned by many other drugmakers, may hold a key to building its share of the global market for branded antibiotics, estimated at $9.5 billion in 2011, according to data compiled by Bloomberg Industries. “Most antibiotics in use today are derived from natural products,” Cubist Chief Executive Officer Michael Bonney said in an interview. “They are nature’s way of arming bacteria in the soil so it can protect its homeland.”